Icon

QNASL (nda202813)- (0.04MG/ACTUATION,0.08MG/ACTUATION)

BECLOMETHASONE DIPROPIONATE TEVA BRANDED PHARM
0.04MG/ACTUATION,0.08MG/ACTUATION
No Yes
2031-Oct-21 Expired
None 2015-Mar-23
None No
QNASL Nasal Aerosol is a corticosteroid indicated for the treatment of nasal symptoms associated with seasonal and perennial allergic rhinitis in patients 4 years of age and older.
0 0 0
Total Other Developers 2
Drugs with Suitability No
0.04MG/ACTUATION ** ** Up - -
0.08MG/ACTUATION ** ** Up - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.